Lack of benefit from anti-EGFR treatment in RAS and BRAF...

  • Main
  • 2019 / 3
  • Lack of benefit from anti-EGFR treatment in RAS and BRAF...
Clinical Colorectal Cancer 2019 / 3

Lack of benefit from anti-EGFR treatment in RAS and BRAF wild-type metastatic colorectal cancer with mucinous histology or mucinous component

Moretto, Roberto, Morano, Federica, Ongaro, Elena, Rossini, Daniele, Pietrantonio, Filippo, Casagrande, Mariaelena, Antoniotti, Carlotta, Corallo, Salvatore, Marmorino, Federica, Cortiula, Francesco,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2019.02.007
Date:
March, 2019
File:
PDF, 1.22 MB
2019
Conversion to is in progress
Conversion to is failed